Walter Weder

University Hospital of Zurich

Papers

3

Total Citations

45

H-Index

3

About

Walter Weder is a leading thoracic surgeon whose research has fundamentally advanced the surgical management of thymic tumors and lung cancer. His work centers on refining minimally invasive techniques, particularly robotic-assisted thoracoscopic surgery (RATS), for complex thoracic malignancies. Weder’s major contribution is his leadership in establishing the European Society of Thoracic Surgeons (ESTS) prospective thymic database, a powerful global resource that has standardized data collection and enabled collaborative research on thymic tumors, as highlighted in his highly cited 2019 report (37 citations). He has also pioneered the application of minimally invasive sleeve lobectomy for centrally located lung cancer, demonstrating its safety and feasibility in a real-world, propensity-score matched study. Furthermore, Weder has critically evaluated the role of RATS for stage IIIA (c-N2) non-small cell lung cancer, providing evidence that justifies its use in this challenging patient population. His work has directly shaped international guidelines and surgical practice, making complex procedures safer and more accessible while fostering a global collaborative effort to improve outcomes for patients with thoracic malignancies.

Research Focus

Key Achievements

3
H-Index
3
Papers
45
Total Citations
15
Avg Citations/Paper
🏆 Most Cited Paper
Report from the European Society of Thoracic Surgeons prospective thymic database 2017: a powerful resource for a collaborative global effort to manage thymic tumours
37 citations · 2019
📈 Most Prolific Year: 2019 (1 Papers)
🤝 Key Collaborators: 19
🏛 Institutions: University Hospital of Zurich

Top Papers

  1. 1
  2. 2
  3. 3

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago